Furmonertinib Plus Bevacizumab Boosts EGFR-TKI Resistance Outcomes
In a groundbreaking advance for patients grappling with the daunting challenge of leptomeningeal metastasis resistant to epidermal growth factor receptor ...
Tag: third-generation EGFR TKIs
High-Dose Furmonertinib Targets EGFR Exon 20 Insertions
In the ever-evolving landscape of lung cancer research, a recent real-world study published in BMC Cancer shines new light on ...
Fexofenadine Counteracts Osimertinib Resistance in Non-Small Cell Lung Cancer by Targeting c-Met
In a groundbreaking advancement in cancer therapeutics, researchers have unveiled a novel approach to combat resistance to osimertinib, a frontline ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!